November 23 coronavirus news

A percentage of people who recover from Covid-19 experience a set of symptoms – a post Covid syndrome – that is raising concern, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said during a live video interview with The Washington Post national political reporter Robert Costa on Monday.

For people who get seriously ill and are in an ICU intubated on ventilation, “even if it isn’t Covid-19, anyone that goes through that is not going to feel perfectly normal for a considerable period of time,” Fauci said.

“But there’s something else that’s going on with Covid-19,” he continued.

Even in people who haven’t necessarily had serious disease, Fauci said that they are finding anywhere from 20% to maybe 30% of people who have had symptomatic disease “have what’s called a post-Covid syndrome.” The exact percentage isn’t known yet, but a larger cohort study is being done, he said.

“They have a constellation of symptoms and signs that seem to be consistent when you talk to different people,” he said. These include extreme fatigue, shortness of breath – even among people who are athletes – temperature control problems, sleep disturbances and sometimes what is described as brain fog, or difficulty focusing or concentrating.

“So, there are these effects that we’re concerned about,” Fauci said.

The coronavirus pandemic hit a new peak in Turkey with the country’s health ministry reporting the highest number of daily deaths and cases since the start of the outbreak. 

The Turkish health ministry reported 153 Covid-19 related deaths over the last 24 hours, topping the previous high last Friday of 141 deaths. 

The ministry announced 6,713 new Covid-19 "patients" – this is the highest daily number recorded since the start of the pandemic.

Turkey’s daily reported cases are not comparable with the rest of the world.

Since July, the country releases the number of "patients" – this number only includes people showing symptoms and people who have positive PCR tests. The publicly available data does not include asymptomatic cases or those who present clinical signs of Covid-19 but test negative, according to previous health ministry statements. 

The number of new Covid-19 "patients" recorded Monday is higher than any daily cases reported before the decision to exclude asymptomatic cases from public data began in July.

Occupancy rates for ICU beds are now at 71.3% – the highest since the start of the pandemic – with overall hospital bed capacity at 54.7%, the ministry said.

Stricter measures went into effect last week, including limited weekend curfews, age-specific daily lockdowns for people over the age of 65 and under 20, as well as the temporary closure of movie theaters, tea houses, pool halls, and internet cafes. Restaurants and cafes have been restricted to delivery and take-out only and schools have been moved online. In Istanbul, the local pandemic board has also started implementing outdoor smoking bans in certain neighborhoods, squares and streets. 

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said on Monday that AstraZeneca's vaccine candidate showing 70% efficacy on average is "good news," but he is waiting to be briefed on the data.

AstraZeneca's announcement noted that the 70% efficacy of its vaccine is actually the average of two very different vaccination schedules tested in its trials in the United Kingdom and Brazil.

One schedule included 2,741 study participants who were given a half dose, followed by a full dose at least one month apart – that showed an efficacy of 90%. The other schedule included 8,895 study participants who were given two full doses at least one month apart – that showed 62% efficacy.

"To have a 90% efficacy in one of the components – mainly one dose range of the components, which was a half a dose first followed by a full dose – that's good news," Fauci said.

"What that tells us now is that this is the third vaccine that we have giving a very high degree of efficacy, which bodes well for vaccinology in general, in the context of Covid-19," Fauci said. "We would like to have multiple candidates that are highly efficacious."

There have been at least 12,282,123 cases of coronavirus in the US, and at least 256,934 people have died, according to data from Johns Hopkins University.

So far today, Johns Hopkins has reported 35,274 new cases and 152 reported deaths.

The totals include cases from all 50 states, the District of Columbia and other US territories, as well as repatriated cases. 

The Institute for Health Metrics and Evaluation at the University of Washington predicts that by the start of January, more than 2,000 people in the US will die every day from Covid-19.

It warns, if behavior doesn't change, total US deaths could reach more than 471,000 by March 1, and the group says hospital systems, particularly ICUs, are expected to be "under extreme stress in December and January in 18 states."

That's why CNN's Chief Medical Correspondent Dr. Sanjay Gupta says he won't be spending the holidays with his family this year and is advising others to follow his example.

In a CNN article he wrote on Saturday, Gupta says:

However, if you are planning on hosting or attending a holiday gathering, Gupta suggests some modifications you can make to limit the risk.

Watch his tips here.

New York, New Jersey and Connecticut — known around New York City and its outlying suburbs as the Tri-State Area — have jointly surpassed one million Covid-19 cases, according the Johns Hopkins University’s Coronavirus Resource Center.

Here's a breakdown of the Covid-19 cases by state, according to JHU:

Combined, the three states’ total is 1,003,690 identified positive cases. The US has surpassed 12 million Covid-19 infections and 256,000 deaths.

Two states have each surpassed 1 million cases alone, as Texas has confirmed at least 1,153,612 cases and California has reported 1,114,524 cases since the onset of the pandemic. 

Florida is close behind, at 938,414 cases.

Oklahoma reported Monday more than 3,500 new Covid-19 cases. It is the third day in a row the state has reported more than 3,000 new cases. 

There are now 177,874 total cases in the state, up 3,544 since the last report. The Oklahoma State Department of Health also reported 15 new deaths, bringing the total to 1,649.

The state's dashboard shows that only 5% of the state's intensive care unit beds are available. There are currently 1,495 patients hospitalized with the virus.

Note: These numbers were released by the state's public health agency and may not line up exactly in real time with CNN’s database drawn from Johns Hopkins University and the Covid Tracking Project.   

Pennsylvania’s top health official says latest models show the state “could run out of ICU beds within a week,” according to a news release.

Newly reported data shows hospitalizations increasing, an increase in the use of ventilators, and a percent positivity which Secretary of Health Dr. Rachel Levine calls “worrisome.”

Pennsylvania reported a seven day case increase of over 36,000 cases and a statewide positivity of 11.1%, according to the release.

That data, as of Nov. 19, shows an increase of 8,807 more new cases across the state over the past week compared to the previous week.

The statewide positivity jumped from 9.6% to 11.1%.

AstraZeneca's coronavirus vaccine candidate comes with the advantage of requiring refrigeration at temperatures that are easier to reach, compared with some other vaccine candidates, a World Health Organization official pointed out during a news briefing on Monday.

WHO Chief Scientist Dr. Soumya Swaminathan said that the vaccine can be stored and is stable in temperatures of 2 to 8 degrees Celsius. In comparison, Pfizer's vaccine needs to be stored at about minus 75 degrees Celsius.

Regarding AstraZeneca's Covid-19 vaccine candidate, "The advantage of this vaccine is that it can be stored in the ordinary refrigerated temperatures," Swaminathan said.

"That of course has huge logistical advantages for transporting and delivering this vaccine to cities and towns and villages and rural areas around the world. And we hope there will be more vaccines like that, which are more heat stable," Swaminathan said.

"We have to also continue to encourage all the other developers who are doing clinical trials and were in early phases of development, because we do need a variety of vaccines out there that will target different groups that will have different storage conditions," Swaminathan said. "The issue of affordability is also important to keep in mind."